Blockade of P2X7 receptors preserves blood retinal barrier integrity by modulating the plasmalemma vesicle‐associated protein: Implications for diabetic retinopathy

High levels of glucose increased PLVAP expression in HRMECs, which was blocked by JNJ47965567. Furthermore, JNJ47965567 preserved VE-cadherin and ZO-1. In the choroidal vasculature of diabetic mice, PLVAP immunostaining was increased, compared to levels in non-diabetic mice. This increase was significantly attenuated by treatment with JNJ47965567 CONCLUSIONS AND IMPLICATIONS: This study showed that P2X7 receptor signalling is an important component of a complex gene regulatory network, including PLVAP, mediating the pathophysiology of diabetic retinopathy. The P2X7 receptor antagonist JNJ47965567 showed a good pharmacodynamic profile, suggesting that this approach could be of value in the treatment of diabetic retinopathy.

Authors

Institutions

Publication Details

Journal
British Journal of Pharmacology
Published
2025-02-20
DOI
https://doi.org/10.1111/bph.70007
Citations
4
Primary Topic
Adenosine and Purinergic Signaling
Type
article
Field-Weighted Citation Impact
4.47

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Blockade of P2X7 receptors preserves blood retinal barrier integrity by modulating the plasmalemma vesicle‐associated protein: Implications for diabetic retinopathy

Kenneth Patrick Mitton, Cornel Baltă, Federica Conti, Giuseppe Nicosia et al.
4 citations
British Journal of Pharmacology
Adenosine and Purinergic Signaling
4.47
article

Blockade of P2X7 receptors preserves blood retinal barrier integrity by modulating the plasmalemma vesicle‐associated protein: Implications for diabetic retinopathy

Kenneth Patrick Mitton, Cornel Baltă, Federica Conti, Giuseppe Nicosia, Alina Ciceu, Francesca Lazzara, Hildegard Herman, Anca Hermenean, Naomi Haque, Chiara Bianca Maria Platania, Maria Consiglia Trotta, Michele D’Amico, Claudio Bucolo, Settimio Rossi, Filippo Drago, Wendelin Dailey, Erika Giuffrida
article en
4 citations

Abstract

High levels of glucose increased PLVAP expression in HRMECs, which was blocked by JNJ47965567. Furthermore, JNJ47965567 preserved VE-cadherin and ZO-1. In the choroidal vasculature of diabetic mice, PLVAP immunostaining was increased, compared to levels in non-diabetic mice. This increase was significantly attenuated by treatment with JNJ47965567 CONCLUSIONS AND IMPLICATIONS: This study showed that P2X7 receptor signalling is an important component of a complex gene regulatory network, including PLVAP, mediating the pathophysiology of diabetic retinopathy. The P2X7 receptor antagonist JNJ47965567 showed a good pharmacodynamic profile, suggesting that this approach could be of value in the treatment of diabetic retinopathy.

British Journal of PharmacologyVol. 182(12)
Oakland University (US), University of Campania "Luigi Vanvitelli" (IT), University of Catania (IT), Vasile Goldis Western University of Arad (RO), Smith-Kettlewell Eye Research Institute (US)
Ministero dell’Istruzione, dell’Università e della Ricerca, National Institutes of Health, National Eye Institute, Precursory Research for Embryonic Science and Technology
Openalex Percentile: Top 7%
Adenosine and Purinergic Signaling
4.47
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.